抗藥性金黃色葡萄球菌(MRSA) 檢測系統市場：依產品類型、檢測類型、最終用戶和地區分類

Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product, By Test Type, By End User, and by Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，抗藥性金黃色葡萄球菌(MRSA) 檢測系統市場規模將達到 1.921 億美元，到 2033 年將達到 3.989 億美元。預計 2026 年至 2033 年的複合年成長率將達到 11.0%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1.921億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.00%	2033年市場規模預測：	3.989億美元

抗藥性金黃色葡萄球菌(MRSA) 檢測系統市場的擴張受到多種因素的驅動，包括葡萄球菌感染疾病的上升、新型 MRSA 檢測系統的推出以及醫療保健領域自動化和系統整合技術的進步。儘管市場正在成長，但也面臨著諸如熟練的醫療保健專業人員短缺等挑戰。然而，某些市場趨勢，例如採用晶片實驗室技術的快速檢測抗藥性金黃色葡萄球菌(MRSA) 檢測系統的日益普及，以及用於快速臨床檢測 MRSA 的無 PCR 電化學即時檢測 (POC) 技術的出現，預計將進一步推動市場成長。

市場動態

主要市場參與者正致力於採取諸如推出新產品等成長策略，預計將推動全球抗藥性金黃色葡萄球菌(MRSA) 檢測系統市場的成長。例如，2023 年 6 月 2 日，致力於利用人工智慧驅動的分子製造和免疫分析技術改善美國標準治療的個人化醫療公司 BostonGene 宣布推出獲得 CLIA 認證和 CAP 認可的抗藥性金黃色葡萄球菌(MRSA) 檢測、免疫分析和太空蛋白質組學解決方案。這些解決方案整合了多種基於人工智慧的分子和免疫分析技術，能夠分析腫瘤、微環境和宿主免疫，從而提供患者疾病的全面資訊。除了「BostonGene 腫瘤畫像」檢測外，這些服務還能支持並提高臨床試驗和研發活動的效率。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數，對全球抗藥性金黃色葡萄球菌(MRSA) 檢測系統市場的主要參與者進行了概況介紹：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球抗藥性金黃色葡萄球菌(MRSA) 檢測系統市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球抗藥性金黃色葡萄球菌(MRSA) 檢測系統市場中使用的各種策略矩陣，相關人員將能夠做出更順利的決策。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- F.Hoffmann-La Roche
- Becton, Dickinson and Company
- Hain Lifescience GmbH
- BioMA（C）rieux
- 3M Company
- Bio-Rad Laboratories Inc.
- Abacus Diagnostica
- Abbott Laboratories
- Puritan Medical Products
- Diatherix Eurofins, LLC
- Arlington Scientific Inc.
- AdvanDx
- Genspeed Biotech GmbH
- Cepheid Inc.
- Luminex Corporation
- R-Biopharm AG

第10章

參考
調查方法

簡介目錄

Product Code: CMI3803

Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market is estimated to be valued at USD 192.1 Mn in 2026 and is expected to reach USD 398.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 192.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.00%	2033 Value Projection:	USD 398.9 Mn

The methicillin resistant staphylococcus aureus (MRSA) testing systems market expansion relies on various elements such as the escalating prevalence of staphylococcal infections, the implementation of novel methicillin resistant staphylococcus aureus (MRSA) testing systems diagnostic tests, and the enhanced integration of automation and systems in the healthcare sector. While the market demonstrates growth, it also faces obstacles like a scarcity of skilled practitioners. However, certain market trends like the increasing utilization of methicillin resistant staphylococcus aureus (MRSA) testing systemsquick tests employing lab-on-chip technology and the emergence of PCR-free electrochemical point-of-care (POC) testing for swift clinical detection of MRSA will stimulate the market growth.

Market Dynamics

The key market players are focusing on the adoption of growth strategies such as product launches, and this is expected to drive the global methicillin resistant staphylococcus aureus (MRSA) testing systems market growth. For instance, on June 02, 2023, BostonGene Iis personalized medicine using AI-based molecular manufacturing and immune profiling to improve the standard of care in U.S, announced the launch of its CLIA-certified and CAP-accredited methicillin resistant staphylococcus aureus test, immunoprofiling, and spatial proteomics solutions that provide a holistic view of a patient's disease by integrating multiple AI-based molecular and immune profiling techniques that analyze tumor, micro-environment, and host immunity. The offerings, in addition to the BostonGene Tumor Portrait test, will support and improve the efficacy of clinical trials and research and development efforts.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global methicillin resistant staphylococcus aureus (MRSA) testing systems market based on the following parameters- Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include include Hoffmann-La Roche, Becton, Dickinson and Company, Hain Lifescience GmbH, BioMerieux, 3M Company, Bio-Rad Laboratories Inc., Abacus Diagnostica, Abbott Laboratories, Puritan Medical Products, Diatherix Eurofins, LLC, Arlington Scientific Inc., AdvanDx, Genspeed Biotech GmbH, Cepheid Inc., Luminex Corporation, and R-Biopharm AG.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global methicillin resistant staphylococcus aureus (MRSA) testing systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global methicillin resistant staphylococcus aureus (MRSA) testing systems market.

Detailed Segmentation:

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Instruments
- Reagents & Kits
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Test Type (Revenue, USD Mn, 2021 - 2033)
- Immunodiagnostic Test
- Molecular Diagnostic Test
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
F.Hoffmann-La Roche
Becton, Dickinson and Company
Hain Lifescience GmbH
BioMerieux
3M Company
Bio-Rad Laboratories Inc.
Abacus Diagnostica
Abbott Laboratories
Puritan Medical Products
Diatherix Eurofins, LLC
Arlington Scientific Inc.
AdvanDx
Genspeed Biotech GmbH
Cepheid Inc.
Luminex Corporation
R-Biopharm AG.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
Economic Impact
Impact on Supply and Demand

5. Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type, 2021€"2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Mn)
- Segment Trends
Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Mn)
- Segment Trends

6. Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Test Type, 2021€"2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
Immunodiagnostic Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Mn)
- Segment Trends
Molecular Diagnostic Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Mn)
- Segment Trends

7. Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By End User, 2021 €" 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Mn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)

8. Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Region, 2021€"2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth By Product Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Test Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By End User, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Country, 2021€"2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth By Product Type, 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Test Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By End User, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Country, 2021€"2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth By Product Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Test Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By End User, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Country, 2021€"2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth By Product Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Test Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By End User, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Country, 2021€"2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth By Product Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Test Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By End User, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Country, 2021€"2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth By Product Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Test Type, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By End User, 2021€"2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth By Country/Sub-region, 2021€"2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- F.Hoffmann-La Roche *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Becton, Dickinson and Company
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hain Lifescience GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- BioMA(C)rieux
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- 3M Company
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bio-Rad Laboratories Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abacus Diagnostica
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott Laboratories
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Puritan Medical Products
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Diatherix Eurofins, LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Arlington Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AdvanDx
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Genspeed Biotech GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cepheid Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Luminex Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- R-Biopharm AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies